Psychiatry Research: Neuroimaging
Volume 182, Issue 3 , Pages 223-230 , 30 June 2010

Caudate nucleus volume in individuals at ultra-high risk of psychosis: A cross-sectional magnetic resonance imaging study

  • Katrina L. Hannan

      Affiliations

    • Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • Corresponding Author InformationCorresponding author. Melbourne Neuropsychiatry Centre, c/o Sunshine Hospital, 176 Furlong Road, St. Albans, Vic 3021, Australia. Tel.: +61 3 8345 1303; fax: +61 3 8345 0599.
    • ,
  • Stephen J. Wood

      Affiliations

    • Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • ,
  • Alison R. Yung

      Affiliations

    • ORYGEN Research Centre, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • ,
  • Dennis Velakoulis

      Affiliations

    • Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • ,
  • Lisa J. Phillips

      Affiliations

    • Department of Psychology, The University of Melbourne, Parkville, Victoria, Australia
    • ,
  • Bridget Soulsby

      Affiliations

    • Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • ,
  • Gregor Berger

      Affiliations

    • ORYGEN Research Centre, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • Integrated Psychiatry Winterthur IPW, Department of Adolescent Psychiatry, Winterthur, Zurich, Switzerland
    • ,
  • Patrick D. McGorry

      Affiliations

    • ORYGEN Research Centre, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia
    • ,
  • Christos Pantelis

      Affiliations

    • Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria, Australia

Received 1 May 2009 ,Revised 24 December 2009 ,Accepted 11 February 2010.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition revised. Washington DC: APA; 1987;
  2. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa; 1983;
  3. Ballmaier M, Schlagenhauf F, Toga AW, Gallinat J, Koslowski M, Zoli M, et al. Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophrenia Research. 2008;106:140–147
  4. Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pflüger MO, Stieglitz R, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophrenia Research. 2008;106:108–114
  5. Brown KW, White T, Wardlaw JM, Walker N, Foley D. Caudate nucleus morphology in tardive dyskinesia. British Journal of Psychiatry. 1996;169(5):631–636
  6. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry. 1992;49:966–974
  7. Chakos MH, Lieberman JA, Bilder R, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry. 1994;151:1430–1436
  8. Chakos MH, Lieberman JA, Alvir J, Bilder R, Borenstein M, Lerner G, et al. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet. 1995;345:456–457
  9. Chua SE, Cheung C, Cheung V, Tsang JTK, Chen EYH, Wong JCH, et al. Cerebral grey, white matter and csf in never-medicated first-episode schizophrenia. Schizophrenia Research. 2007;89:12–21
  10. Chua SE, Deng Y, Chen EYH, Law CW, Chiu CPY, Cheng C, et al. Early striatal hypertrophy in first-episode psychosis within 3weeks of initiating antipsychotic drug treatment. Psychological Medicine. 2008;39:793–800
  11. Corson PW, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biological Psychiatry. 1999;46:712–720
  12. Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, et al. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proceedings of the National Academy Science of the United States of America. 1998;95(19):11406–11411
  13. DeLong MR. The basal ganglia. In:  Kandel ER,  Schwartz JH editor. Principles of Neural Science. New York: McGraw-Hill Co. Inc; 2000;
  14. Fornito A, Yücel M, Wood SJ, Stuart GW, Buchanan J-A, Proffitt T, et al. Individual differences in anterior cingulate/paracingulate morphology are related to executive functions in healthy males. Cerebral Cortex. 2004;14:424–431
  15. Fornito A, Yucel M, Wood SJ, Proffitt T, McGorry PD, Velakoulis D, et al. Morphology of the paracingulate sulcus and executive cognition in schizophrenia. Schizophrenia Research. 2006;88:192–197
  16. Fornito A, Yücel M, Patti J, Wood SJ, Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophrenia Research. 2009;108:104–113
  17. Fray PJ, Robbins TW, Sahakian BJ. Neuropsychiatric applications of CANTAB. International Journal of Geriatric Psychiatry. 1996;11:329–336
  18. Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM. Methods of normalisation of hippocampal volumes measured with MR. AJNR. American Journal of Neuroradiology. 1995;16:637–643
  19. Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Research: Neuroimaging. 2007;154:199–208
  20. Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, Robinson DG, et al. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biological Psychiatry. 2002;51:801–808
  21. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. American Journal of Psychiatry. 1998;155:1711–1717
  22. Hokama H, Shenton ME, Nestor PG, Kikinis R, Levitt JJ, Metcalf D, et al. Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatric Research: Neuroimaging. 1995;61:209–229
  23. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 1996;153:41–49
  24. Jayakumar PN, Venkatasubramanian G, Keshavan MS, Srinivas JS, Gangadhar BN. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naive schizophrenia. Acta Psychiatrica Scandinavica. 2006;114:346–351
  25. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825–841
  26. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage. 2005;25:1023–1030
  27. Keshavan MS, Bagwell WW, Haas G, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet. 1994;344(8934):1434
  28. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry. 1998;155(6):774–778
  29. Koo M, Levitt JJ, McCarley RW, Seidman LJ, Dickey CC, Niznikiewicz MA, et al. Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder. Biological Psychiatry. 2006;60:40–48
  30. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. American Journal of Psychiatry. 2001;158:625–631
  31. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. American Journal of Psychiatry. 2004;161:1829–1836
  32. Langen M, Schnack HG, Nederveen H, Bos D, Lahuis BE, de Jonge MV, et al. Changes in the developmental trajectories of striatum in autism. Biological Psychiatry. 2009;66:327–333
  33. Lawrie SM, Whalley H, Abukmeil SS, Kestelman JN, Donnelly L, Miller P, et al. Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biological Psychiatry. 2001;49:811–823
  34. Levitt JJ, McCarley RW, Dickey CC, Voglmaier MM, Niznikiewicz MA, Seidman LJ, et al. MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. American Journal of Psychiatry. 2002;159(7):1190–1197
  35. Levitt JJ, Westin CF, Nestor PG, Estepar RSJ, Dickey CC, Voglmaier MM, et al. Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biological Psychiatry. 2004;55:177–184
  36. Levitt JJ, Styner M, Niethammer M, Bouix S, Koo M, Voglmaier MM, et al. Shape abnormalities of caudate nucleus in schizotypal personality disorder. Schizophrenia Research. 2008;110:127–139
  37. Levy R, Friedman HR, Davachi L, Goldman-Rakic PS. Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. Journal of Neuroscience. 1997;17:3870–3882
  38. Liddle PF, Pantelis C. Brain imaging in schizophrenia. In:  Hirsch SR, W., D.R.  editor. Schizophrenia. Oxford, UK: Blackwell; 2003;
  39. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry. 2005;62:361–370
  40. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Research. 2007;89:59–71
  41. Mamah D, Harms MP, Wang L, Barch D, Thompson P, Kim J, et al. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biological Psychiatry. 2008;64:111–120
  42. Manoach DS, Gollub RL, Benson ES, Searly MM, Goff DC, Halpern E, et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biological Psychiatry. 2000;48:99–109
  43. Maxwell ME. Unpublished manual for the FIGS. In: Clinical Neurogenetics Branch, Intramural Research Program. National Institute of Health; 1992;
  44. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. Journal of Neuropsychiatry and Clinical Neuroscience. 1994;6:358–370
  45. Mion CC, Andreasen NC, Arndt S, Swayz VW, Cohen GA. MRI abnormalities in tardive dyskinesia. Psychiatric Research. 1991;40:157–166
  46. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belge A. Imaging frontostriatal functions in ultra-high-risk, early- and chronic schizophrenia during executive processing. Archives of General Psychiatry. 2005;62:254–262
  47. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the new adult reading test. Cortex. 1978;14:234–244
  48. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports. 1962;10:799–812
  49. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lobes lesions in man. Neuropsychologia. 1990;28:1021–1034
  50. Pantelis C, Brewer W. Neuropsychological and olfactory dysfunction in schizophrenia: relationship of frontal syndromes to syndromes of schizophrenia. Schizophrenia Research. 1995;17:35–45
  51. Pantelis C, Maruff P. The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. Journal of Psychosomatic Research. 2002;53:655–664
  52. Pantelis C, Barnes TR, Nelson HE. Is the concept of frontal-subcortical dementia relevant to schizophrenia?. British Journal of Psychiatry. 1992;160:442–460
  53. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain. 1997;120:1823–1843
  54. Pantelis C, Barber FZ, Barnes TRE, Nelson HE, Owen AM, Robbins TW. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophrenia Research. 1999;37:251–270
  55. Pantelis C, Stuart GW, Nelson HE, Robbins TW, Barnes TRE. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. American Journal of Psychiatry. 2001;158:1276–1285
  56. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361(9354):281–288
  57. Pantelis C, Proffitt TM, Wood SJ, O'Brien CL, Henry LP, Harris MG, et al. The Melbourne first-episode medium term follow-up study: decline in attentional set-shifting but not spatial working memory after the onset of psychosis. Schizophrenia Bulletin. 2007;33:572
  58. Pantelis C, Wood SJ, Proffitt TM, Testa R, Mahony K, Brewer WJ, et al. Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory. Schizophrenia Research. 2009;112(1–3):104–113
  59. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Archives of General Psychiatry. 1992;49(12):975–982
  60. Rajarethinam R, Upadhyaya A, Tsou P, Upadhyaya M, Keshavan MS. Caudate volume in offspring of patients with schizophrenia. British Journal of Psychiatry. 2007;191:258–259
  61. Robbins TW. The case for frontostriatal dysfunction in schizophrenia. Schizophrenia Bulletin. 1990;16:429–438
  62. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N, et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage. 2003;19:365–375
  63. In:  Schonell FJ editors. Backwardness in the Basic Subjects. London: Oliver and Boyd; 1942;
  64. Shihabuddin L, Buchsbaum MS, Hazlett EA, Haznedar M, Harvey PD, Newman A, et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Archives of General Psychiatry. 1998;55(3):235–243
  65. Siegel BV, Buchsbaum MS, Bunney WE, Gottschalk LA, Haier RJ, Lohr JB, et al. Cortical–striatal–thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry. 1993;152:1325–1336
  66. Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn MLC, Jellema K, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. American Journal of Psychiatry. 2000;157:416–421
  67. Sun D, Phillips LJ, Velakoulis D, Yung A, McGorry PD, Wood SJ, et al. Progressive brain structural changes mapped as psychosis develops in “at risk” individuals. Schizophrenia Research. 2009;108:85–92
  68. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, et al. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry. 2009;14:976–986
  69. Tauscher-Wisniewski S, Tauscher J, Logan J, Christensen BK, Mikulis DJ, Zipiursky RB. Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study. Schizophrenia Research. 2002;58(2–3):185–188
  70. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry. 2006;63(2):139–149
  71. In:  Wechsler D editors. The Weschler Adult Intelligence Scale—Revised. New York: The Psychological Corporation; 1981;
  72. Wood SJ, Pantelis C, Proffitt T, Phillips LJ, Stuart GW, Buchanan JA, et al. Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine. 2003;33(7):1239–1247
  73. Wood SJ, Yucel M, Velakoulis D, Phillips LJ, Yung AR, Brewer W, et al. Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophrenia Research. 2005;75(2–3):295–301
  74. Worth AJ, Makris N, Caviness VS, Kennedy DN. Neuroanatomical segmentation in MRI: technological objectives. International Journal of Pattern Recognition and Artificial Intelligence. 1997;11:1161–1187
  75. Yung AR, Philips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research. 2004;67:131–142

PII: S0925-4927(10)00072-7

doi: 10.1016/j.pscychresns.2010.02.006

Psychiatry Research: Neuroimaging
Volume 182, Issue 3 , Pages 223-230 , 30 June 2010

Article Tools

* Image Usage & Resolution